We are live on ! Find out more
HQY icon

HealthEquity

366 hedge funds and large institutions have $7.07B invested in HealthEquity in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 122 increasing their positions, 138 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more call options, than puts

Call options by funds: $16.2M | Put options by funds: $10.3M

50% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 36

24% more capital invested

Capital invested by funds: $5.71B → $7.07B (+$1.36B)

4% more funds holding

Funds holding: 352366 (+14)

0.19% more ownership

Funds ownership: 100.36%100.55% (+0.19%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

12% less repeat investments, than reductions

Existing positions increased: 122 | Existing positions reduced: 138

Holders
366
Holders Change
+14
Holders Change %
+3.98%
% of All Funds
5.27%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
54
Increased
122
Reduced
138
Closed
36
Calls
$16.2M
Puts
$10.3M
Net Calls
+$5.88M
Net Calls Change
+$1.77M
Name Holding Trade Value Shares
Change
Change in
Stake
GCM
26
Geneva Capital Management
Wisconsin
$70.7M -$404K -5,169 -0.6%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$65.5M -$2.21M -28,324 -3%
BAMCO Inc
28
BAMCO Inc
New York
$65.3M
GKIM
29
GW&K Investment Management
Massachusetts
$64.9M -$1.13M -14,491 -2%
Wellington Management Group
30
Wellington Management Group
Massachusetts
$53.9M -$581K -7,440 -1%
Bank of America
31
Bank of America
North Carolina
$52.5M +$12.6M +161,396 +34%
Morgan Stanley
32
Morgan Stanley
New York
$52.3M -$73.8M -944,613 -60%
VNIM
33
Vaughan Nelson Investment Management
Texas
$49.4M +$47.3M +605,710 New
ACB
34
Aristotle Capital Boston
Massachusetts
$47.6M -$1.31M -16,729 -3%
Kayne Anderson Rudnick Investment Management
35
Kayne Anderson Rudnick Investment Management
California
$46.8M -$656K -8,407 -1%
SEI Investments
36
SEI Investments
Pennsylvania
$46.5M +$1.01M +12,958 +2%
N
37
Nuveen
North Carolina
$46.4M -$267K -3,417 -0.6%
American Century Companies
38
American Century Companies
Missouri
$45.2M +$3.03M +38,858 +8%
GF
39
Greenhouse Funds
Maryland
$41.3M +$39.5M +506,465 New
DC
40
Davenport & Co
Virginia
$35.4M -$5.76M -73,751 -15%
EP
41
Eversept Partners
New York
$34.4M -$5.74M -73,574 -15%
AAM
42
Aureus Asset Management
Massachusetts
$33.6M -$425K -5,437 -1%
UBS Group
43
UBS Group
Switzerland
$30.6M +$26.9M +344,841 +1,168%
Massachusetts Financial Services
44
Massachusetts Financial Services
Massachusetts
$30.5M -$4.19M -53,705 -13%
Principal Financial Group
45
Principal Financial Group
Iowa
$29.7M +$1.05M +13,385 +4%
Macquarie Group
46
Macquarie Group
Australia
$29.7M +$1.48M +19,013 +6%
Victory Capital Management
47
Victory Capital Management
Texas
$29.4M -$4.22M -54,043 -13%
OAM
48
Ophir Asset Management
Australia
$28.4M +$2.35M +30,065 +9%
ACM
49
Ashford Capital Management
Delaware
$27.9M -$5.24M -67,170 -16%
Ensign Peak Advisors
50
Ensign Peak Advisors
Utah
$27.8M +$4.9M +62,753 +23%

HQY Hedge Fund Activity: Q1 2024 in Review

366 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q1 2024, worth a combined $7.07B — up 24% from $5.71B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new HQY positions and 36 closed out — a net gain of 18 holders — while 122 added to existing stakes and 138 trimmed.

The largest buyer was Invesco, adding an estimated $64.8M. The largest seller was Morgan Stanley, cutting an estimated $73.8M.

  • 366 institutional investors held HealthEquity (HQY) as of Q1 2024, up from 352 in Q4 2023.
  • Funds reported $7.07B of HealthEquity stock for Q1 2024, up 24% quarter-over-quarter.
  • 54 funds opened new HealthEquity positions in Q1 2024 and 36 closed out, a net change of +18 holders.
  • The largest HealthEquity buyer in Q1 2024 was Invesco, an estimated $64.8M added.
  • The largest HealthEquity seller in Q1 2024 was Morgan Stanley, an estimated $73.8M sold.

Based on aggregated 13F filings for Q1 2024.